- Sigma receptor scintigraphy with N-[2-(1'-piperidinyl)ethyl]-3-(123)I-iodo-4-methoxybenzamide of patients with suspected primary breast cancer: first clinical results. Caveliers, V., Everaert, H., John, C.S., Lahoutte, T., Bossuyt, A. J. Nucl. Med. (2002)